Launched in collaboration with IIT Madras’ Healthcare Technology Innovation Centre (HTIC), this portable assay is a Fluorescence Immunoassay Analyzer for quantitative and qualitative determination of blood test parameter.
By Team ABLE
To transform India’s healthcare scenario by providing cost-effective diagnostic solutions in remote locations and limited-resources settings, J. Mitra has launched India’s first portable diagnostic solution - the iQuant immunoassay analyzer in the Indian market.
Launched in collaboration with IIT Madras’ Healthcare Technology Innovation Centre(HTIC), this portable assay is a Fluorescence Immunoassay Analyzer for quantitative and qualitative determination of blood test parameter – that includes TSH (Thyroid Stimulating Hormone), T3 (Tri-iodo thyronine), T4 (Thyroxin), Vitamin D, Dengue NS1 Antigen, Dengue IgM, Dengue IgG and HbA1c test.
According to the company, Beta-testing for the product had been going on for the past 8 months and has generated tremendous positive response and demand. With this launch, various highly-active and sought-after diagnostic solutions will be available across the country and in the remotest of locations at the fraction of a cost.
J. Mitra will be adding to the number of diagnostic solutions, which will be available as a software upgrade on the cloud. Speaking on the occasion, Jatin Mahajan, managing director, J Mitra said, \"iQuant is an innovative mix – on the product side, it is a mix of science, IT, healthcare and research, while on the implementation side it is great combination of social conditions, ground realities coupled with business sense.\" He further added, \"This is an innovative, path-breaking product that will greatly influence the detection and diagnostic process, which will hasten the treatment and cure process – resulting in a healthier India, in line with government’s healthcare-for-all initiative.\"